Synapse

← Pneumonia

Papers in Pneumonia

Page 2 · newest first

  1. Streptococcus pneumoniae serotype 33H: a novel serotype with frameshift mutations in the acetyltransferase gene wciGPneumonia · 2025
  2. Fluorescent antibody-based detection and ultrastructural analysis of Streptococcus pneumoniae in human sputumPneumonia · 2025
  3. Alterations in the prevalence and serotypes of Streptococcus pneumoniae in elderly patients with community-acquired pneumonia: a meta-analysis and systematic reviewPneumonia · 2025
  4. Outcomes of COVID-19 in the Omicron-predominant wave: large-scale real-world data analysis with a comparison to influenzaPneumonia · 2025
  5. Commonly prescribed medications and risk of pneumonia and all-cause mortality in people with idiopathic pulmonary fibrosis: a UK population-based cohort studyPneumonia · 2025
  6. Can clinical findings at admission allow withholding of antibiotics in patients hospitalized for community acquired pneumonia when a test for a respiratory virus is positive?Pneumonia · 2025
  7. Mortality reduction with 23-valent pneumococcal polysaccharide vaccine: a systematic review and meta-analysisPneumonia · 2024
  8. Pre-vaccination carriage prevalence of Streptococcus pneumoniae serotypes among internally displaced people in Somaliland: a cross-sectional studyPneumonia · 2024
  9. Oxygenation indices and early prediction of outcome in hypoxemic patients with COVID-19 pneumonia requiring noninvasive respiratory support in pulmonary intermediate care unitPneumonia · 2024
  10. Pneumococci remain the main cause of complicated pediatric pneumonia in the post-pandemic era despite extensive pneumococcal vaccine usePneumonia · 2024
  11. Community versus academic hospital community-acquired pneumonia patients: a nested cohort studyPneumonia · 2024
  12. Seroprevalence and prognostic value of Aspergillus-specific IgG among non-neutropenic invasive pulmonary aspergillosis patients: a prospective multicenter studyPneumonia · 2024
  13. Epidemiology, clinical and biological characteristics, and prognosis of critically ill COVID 19 patients: a single-center experience through 4 successive wavesPneumonia · 2024
  14. Streptococcus pneumoniae serotype distribution in Bangladeshi under-fives with community-acquired pneumonia pre-10-valent pneumococcal conjugate vaccinationPneumonia · 2024
  15. Clinical implications of persistently increased blood urea nitrogen/serum creatinine ratio (PI-BUN/Cr) in severe COVID-19 patientsPneumonia · 2024
  16. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae in China among children under 14 years of age post-implementation of the PCV13: a systematic review and meta-analysis (2017–2024)Pneumonia · 2024
  17. Radiographically confirmed pneumonia in Malawian children and associated pneumococcal carriage after introduction of the 13-valent pneumococcal conjugate vaccinePneumonia · 2024
  18. Relationships between human serum albumin levels and septic shock, in-hospital, and out-of-hospital mortality in elderly patients with pneumonia in different BMI rangesPneumonia · 2024
  19. Etiology and antimicrobial susceptibility patterns of bacteria causing pneumonia among adult patients with signs and symptoms of lower respiratory tract infections during the COVID-19 pandemic in Mwanza, Tanzania: a cross-sectional studyPneumonia · 2024
  20. The importance of Haemophilus influenzae in community-acquired pneumonia: an emerging pathogen in the elderly regardless of comorbidities compared to Streptococcus pneumoniaePneumonia · 2024
  21. Time to recovery from severe community-acquired pneumonia and its predictors among 6 to 59 months of age children admitted to South Wollo zone public hospitals, North East Ethiopia: a prospective follow-up studyPneumonia · 2024
  22. Factors associated with severe pneumonia among children <5 years, Kasese District, Uganda: a case-control study, January–April 2023Pneumonia · 2024
  23. Early detection of tuberculosis: a systematic reviewPneumonia · 2024
  24. Obtaining patient phenotypes in SARS-CoV-2 pneumonia, and their association with clinical severity and mortalityPneumonia · 2024
  25. Back to the future: the novel art of digital auscultation applied in a prospective observational study of critically ill Covid-19 patientsPneumonia · 2024
  26. Invasive pulmonary aspergillosis among patients with severe community-acquired pneumonia and influenza in ICUs: a retrospective cohort studyPneumonia · 2024
  27. Accuracy of the recording of pneumonia events in English electronic healthcare record data in patients with chronic obstructive pulmonary diseasePneumonia · 2024
  28. Pneumonic-type lung adenocarcinoma with KRAS G12V mutation and sustained response to AfatinibPneumonia · 2024
  29. Should prophylaxis against Pneumocystis jirovecii pneumonia be considered in selected patients with leprosy reactions?Pneumonia · 2024
  30. Sex-dependent vulnerability for Wistar rats model following intranasal instillation with Klebsiella pneumoniae ATCC 43816 causing lobar pneumoniaPneumonia · 2024
  31. Combination of a multiplex pneumonia panel and Gram staining for antimicrobial selection to treat lower respiratory tract infectionPneumonia · 2024
  32. Safety and efficacy of favipiravir in COVID-19 patients with pneumonia. A randomized, double-blind, placebo-controlled study (FAVID)Pneumonia · 2024
  33. The effectiveness of glucocorticoid treatment in post-COVID-19 pulmonary involvementPneumonia · 2024
  34. Serum soluble toll-like receptor 4 and risk for clinical severity in COVID-19 patientsPneumonia · 2024
  35. Host genetic variants associated with susceptibility and severity of pneumococcal pneumonia in adult patientsPneumonia · 2023
  36. Time to recovery and its determinant factors among patients with COVID-19 in Assosa COVID-19 treatment center, Western EthiopiaPneumonia · 2023
  37. A high α1-antitrypsin/interleukin-10 ratio predicts bacterial pneumonia in adults with community-acquired pneumonia: a prospective cohort studyPneumonia · 2023
  38. Risk of subsequent lower respiratory tract infection (LRTI) after hospitalization for COVID-19 LRTI and non-COVID-19 LRTI: a retrospective cohort studyPneumonia · 2023
  39. Thymalfasin therapy accelerates COVID-19 pneumonia rehabilitation through anti-inflammatory mechanismsPneumonia · 2023
  40. Risk of pneumonia in the vicinity of goat farms: a comparative assessment of temporal variation based on longitudinal health dataPneumonia · 2023
  41. A brief history of and future prospects for pneumococcal vaccination in MalaysiaPneumonia · 2023
  42. Clinical algorithm reduces antibiotic use among children presenting with respiratory symptoms to hospital in central VietnamPneumonia · 2023
  43. Effects of pneumococcal conjugate vaccines on reducing the risk of respiratory disease associated with coronavirus infectionPneumonia · 2023
  44. Incidence of non-invasive all-cause pneumonia in children in the United States before and after the introduction of pneumococcal conjugate vaccines: a retrospective claims database analysisPneumonia · 2023
  45. Healthcare resource utilization and cost of pneumococcal disease in children in Germany, 2014–2019: a retrospective cohort studyPneumonia · 2023
  46. Acute organ injury and long-term sequelae of severe pneumococcal infectionsPneumonia · 2023
  47. Innate immune responses in pneumoniaPneumonia · 2023
  48. Pulse oximetry: why oxygen saturation is still not a part of standard pediatric guidelines in low-and-middle-income countries (LMICs)Pneumonia · 2023
  49. Incidence of pneumococcal disease from 2003 to 2019 in children ≤17 years in EnglandPneumonia · 2023
  50. Risk factors for childhood pneumonia at Adama Hospital Medical College, Adama, Ethiopia: a case-control studyPneumonia · 2022